Pages
Posts by category
Landing Pages
Resources
- Clinical and Analytical Evaluation of the Applied BioCode Gastrointestinal Pathogen Panel using KingFisher™ Extraction System
- Evaluation of a Multiplex PCR Assay Using Barcoded Magnetic Bead technology for Detection of Fungal Pathogens in Bronchoalveolar Lavage Fluid
- Clinical and Analytical Evaluation of the Applied BioCode CoV-2 Flu Plus Assay using MagNA Pure 96 and KingFisher Extraction Systems
- MDx-3000 Information Sheet – Technical Support
- Effective Approaches to Diagnostic Stewardship of Syndromic Molecular Panels, 2023
- Applied BioCode – Frequently Asked Questions
- BioCode® GPP Tips for Successful Sample Prep and Extraction with MagNA Pure 96
- BioCode® GPP Tips for Successful Sample Prep and Extraction with NUCLISENS® easyMAG®
- Performance Characterization of the BioCode® STI + Resistance Panel (RUO), 2024
- Simplify Reimbursement with DEX Z-Code® for Applied BioCode Tests
- Package Insert – BioCode® STI + Resistance Panel (RUO)
- BioCode® GPP Tips for Successful Sample Prep and Extraction with KingFisher™ Flex
- Evaluation of a Multiplex Endpoint PCR for the Detection of 22 Fungi Commonly Causing Fungal Pneumonia Using Barcoded Magnetic Bead Technology, 2023
- Evaluation of barcoded magnetic bead–based immunoassays for the simultaneous detection of feline leukemia virus antigen and antibody against feline immunodeficiency virus, 2022
- BioCode® MDx-3000 Brochure
- Package Insert – BioCode® Fungal Panel
- Clinical and Analytical Evaluation of the Applied BioCode CoV-2 Flu Plus Assay using MagNA Pure 96 and KingFisher Extraction Systems
- BioCode® STI + Resistance Panel (RUO) Application Note
- CoA_63-S0001_A-23080001
- CoA_63-G0002_A-24040001
- CoA_63-S0002_A-24040002
- Package Insert – BioCode® SARS-CoV-2 Assay
- BioCode® STI + Resistance Panel Brochure
- The Clinical Performance of the BioCode® Respiratory Pathogen Panel for the Detection of Viruses and Bacteria from Nasopharyngeal Swabs, 2022
- Multicenter Evaluation of BioCode® GPP for Syndromic Molecular Detection of Gastrointestinal Pathogens from Stool Specimens, 2024
- Performance Characterization of a Highly Multiplexed STI + Resistance Panel, 2023
- Safety Data Sheet: BioCode® CoV-2 Flu Plus Assay
- Safety Data Sheet: BioCode® SARS-Cov-2 Assay
- Safety Data Sheet: BioCode® Respiratory Pathogen Panel
- Safety Data Sheet: BioCode® Gastrointestinal Pathogen Panel
- Performance Characterization of a Highly Multiplexed RUO Fungal Pathogen Panel, 2023
- Evaluation of a Multiplex Endpoint PCR for the Detection of 22 Fungi Commonly Causing Fungal Pneumonia Using Barcoded Magnetic Bead Technology, 2023
- BioCode® SARS-CoV-2 Assay
- Package Insert – BioCode® CoV-2 Flu Plus Assay
- Package Insert – BioCode® Gastrointestinal Pathogen Panel
- Package Insert – BioCode® Respiratory Pathogen Panel
- How to Improve Accessibility to Testing for GI Infections
- BioCode® MDx-3000 Trifold
- Development of a Syndromic Molecular Diagnostic Assay for Tick-Borne Pathogens Using Barcoded Magnetic Bead Technology, 2023
- Biocode® Fungal Panel Application Note
- SDS BioCode® Cryptococcus spp. BMB-Probe
- CIO Insights Chris Bernard Cover Story
- SDS BioCode® Pneumocystis jirovecii BMB-Probe
- MDx-3000 Transforming your Lab Experience
- Evaluation of the Applied BioCode® Gastrointestinal Pathogen Panel, 2022
- The BioCode® 2500 Analyzer – System Overview
- User-Defined Mode – BioCode® MDx-3000
- BioCode® MDx-3000 System and Products Overview
- Evaluation of the GPP and RPP Panels at Cleveland Clinic
- Barcoded Magnetic Bead Technology
- Digital Barcodes Detect COVID-19 and 20 Pathogens
- Cytokines & Chemokines Human, Mouse, Rat, Canine, & Monkey Product Information
- Multiplex Cytokine Immunoassay
- DNA Capture Probe BMB Coupling, Hybridization with Biotinylated Target, and SA-PE Reaction
- Package Insert – Nucleic Acid Coupling Kit
- Package Insert – Protein Coupling Kit
- BioCode® CoV-2 Flu Plus Assay kit
- Rules of Procedure for Shareholders Meetings
- Procedures for Ethical Management and Guidelines for Conduct
- Procedures for Election of Directors
- Management of Loans to Others
- Management of Endorsement and Guarantees
- Management of Board Meetings
- Management of Assets
- Ethical Corporate Management Best Practice Principles
- Corporate Social Responsibility Best Practice Principles
- Corporate Governance Best Practice Principles
- Codes of Ethical Conduct
- Audit Committee Charter
- Remuneration Committee Charter
- BioCode® Gastrointestinal Pathogen Panel
- BioCode® SARS-CoV-2 Assay kit
- Quality Management System – ISO 13485:2016 FM 661595
- Evaluation of a Flexible Molecular System for the Detection of Respiratory and Gastrointestinal Pathogens, 2022
- SDS-BioCoder-Pneumocystis-jirovecii-Primer-Pair
- BioCode® Analyte Specifc Reagents* (ASRs) for Fungal Pathogens
- BioCode® Respiratory Pathogen Panel
- SDS BioCode® Cunninghamella bertholletiae BMB-Probe
- SDS-BioCoder-Aspergillus-terreus-BMB-Probe
- SDS-BioCoder-Aspergillus-flavus-BMB-Probe
- SDS-BioCoder-Aspergillus-fumigatus-BMB-Probe
- SDS-BioCoder-Fusarium-oxysporum-BMB-Probe
- SDS-BioCoder-Aspergillus-niger-BMB-Probe
- SDS BioCode® DNA-IC Pack
- SDS BioCode® BMB Diluent
- SDS BioCode® Master Mix A
- SDS BioCode® Scedosporium prolificans BMB-Probe
- SDS BioCode® Scedosporium apiospermum BMB-Probe
- SDS BioCode® Rhizopus spp. BMB-Probe
- SDS BioCode® Rhizopus oryzae BMB-Probe
- SDS BioCode® Rhizopus microsporus BMB-Probe
- SDS BioCode® Rhizomucor spp. BMB-Probe
- SDS BioCode® Mucor indicus BMB-Probe
- SDS BioCode® Fusarium solani BMB-Probe
- BioCode® CoV-2 Flu Plus Assay – EUA Authorization Letter, December 16, 2021
- BioCode® CoV-2 Flu Plus Assay – Fact Sheet for Healthcare Providers
- BioCode® CoV-2 Flu Plus Assay – Fact Sheet for Patients
- BioCode® CoV-2 Assay – “Detects Omicron and Other COVID Variants” Letter, December 6, 2021
- BioCode® Histoplasma capsulatum BMB-Probe
- BioCode® Coccidioides spp. BMB-Probe
- BioCode® Candida tropicalis BMB-Probe
- BioCode® Candida parapsilosis BMB-Probe
- BioCode® Candida lusitaniae BMB-Probe
- BioCode® Candida krusei BMB-Probe
- BioCode® Candida guilliermondii BMB-Probe
- BioCode® Candida glabrata BMB-Probe
- BioCode® Candida dubliniensis BMB-Probe
- BioCode® Candida auris BMB-Probe
- BioCode® Candida albicans BMB-Probe
- BioCode® Blastomyces dermatitidis BMB-Probe
- BioCode® Fungal ITS2 Primer Pair
- BioCode® 2500 – Multiplex MDx and Immunoassay Reader
- SDS – BioCode SA-PE Mix Pack
- BioCode® SARS-CoV-2 Assay Kit – Fact Sheet for Healthcare Providers
- BioCode® SARS-CoV-2 Assay Kit – Fact Sheet for Patients
- BioCode® CoV-2 Assay – “Pooled Sampling” EUA Authorization Letter, December 7, 2020
- BioCode® CoV-2 Assay – EUA Authorization Letter, June 15, 2020
- Clinical Assessment of the Applied BioCode Respiratory Pathogen Panel, 2019
- Validation and Performance of PCR/ Sequencing Assays for Upper Respiratory Pathogens, 2019
- Performance Characterization of a Respiratory Pathogen Panel with an Automated High-Throughput System, 2019
- Barcoded Magnetic Bead Technology
- MSDS – 4096-plex P-Carboxyl BMB
- MSDS – 4096-plex Amino BMB
- MSDS – 4096-plex Carboxyl BMB
- MSDS – BioCode® MDx-3000 Calibration Kit
- Beta Site Evaluation of an 18-Plex Gastrointestinal Pathogen Panel With an Automated, High Throughput System, 2018
- Development and Characterization of a Respiratory Pathogen Panel with an Automated High-Throughput System, 2018
- MSDS – 4096-plex Standard BMB
- MSDS – Detection Buffer with Antifoam
- MSDS – 4096-plex Streptavidin BMB
- MSDS – BioCode® 2500 Calibration Kit
- MSDS: BioCode® MDx 3000 Buffer A
- Evaluation Of MagNA Pure 96 As Alternative Extraction Method for the BioCode® Gastrointestinal Pathogen Panel, 2018
- Development of a Respiratory Pathogen Panel with an Automated High Throughput System – BioCode MDx-3000, 2017
- Validation and Performance of Sequencing-Based Reference Assays for BioCode® GI Panel, 2017
- Performance Evaluation of an 18-Plex Molecular Gastrointestinal Pathogen Panel with an Automated, High-Throughput System, 2017
- Reproducibility and Front-End Extraction Compatability for an 18-Plex Gastrointestinal Pathogen Panel with an Automated, High-Throughput System, 2017
- Characterization of an 18 target Molecular Gastrointestinal Pathogen Panel with High Throughput BioCode® MDx-3000 System, 2016
- Multiplex Molecular Gastrointestinal Pathogen Detection with an Automated Throughput System, 2016
- Advances in multiplex nucleic acid diagnostics for blood-borne pathogens: promises and pitfalls. Expert Review of Molecular Diagnositcs. Early online, 1-13 (2015)
- Development of a Rapid Multiplex Molecular Assay for the Detection of Bacteria from Necrotic Wounds, 2015
- Validation of Methods Producing Spiked Blood and Plasma Samples for Use to Evaluate Analytical Sensitivity and Reproducibility for Rare Pathogens, 2015
- Multiplex Molecular Gastrointestinal Pathogen Detection with an Automated, High Throughput System, 2015
- A User-Friendly Automated System Evaluated With A Multiplex GI Panel Pathogen Detection, 2015
- Deviations in human gut microbiota: a novel diagnostic test for determining dysbiosis in patients with IBS or IBD. Aliment Pharmacol Ther. 2015;42:71-83 (2015).
- MSDS – 128-plex Carboxyl BMB
- BioCode® MDx-3000 For Multiplex GI Pathogen Detection, 2014
- GenomeWeb News–Applied BioCode Developing Multiplex, Bead-Based GI Pathogen Detection Panel (2014)
- SNP Assay Multiplexing Using Barcoded Magnetic Beads in Array Tape™ – Douglas Scientific, LLC (2013)
- Evaluation of the EraGen MultiCode-Plx Respiratory Virus Panel using Barcoded Magnetic Beads designed to Detect Seventeen Respiratory Viruses – Presented at the Clinical Virology Symposium (2011)
- AACC Oak Ridge Conference 2010: Cytokine Panel
- Clinical Virology Symposium (CVS) 2010: Respiratory Virus Panel
Testimonials
Resource Categories
Resource Types
Categories
